About Revage 670
Revåge 670
THE RESULT OF INVESTIGATIONAL STUDIES CONDUCTED BY INDEPENDENT RESEARCHERS SHOWS THE Revåge 670 TMOFFERS DOCUMENTED BENEFITS FOR SHEDDING AND THINNING HAIR. *
The phenomenon of Light. Aggregate data in over a decade of scientific studies of cool laser treatments has yielded impressive data. In European studies, significant increases in hair density and a remarkable 85% success in halting the progression of shedding has been noted. It’s the dynamic, rotational tuning in the Revåge 670TM Cool Laser that optimizes results.
THE RESULT OF INVESTIGATIONAL STUDIES CONDUCTED BY INDEPENDENT RESEARCHERS SHOWS THE Revåge 670 TMOFFERS DOCUMENTED BENEFITS FOR SHEDDING AND THINNING HAIR. *
The phenomenon of Light. Aggregate data in over a decade of scientific studies of cool laser treatments has yielded impressive data. In European studies, significant increases in hair density and a remarkable 85% success in halting the progression of shedding has been noted. It’s the dynamic, rotational tuning in the Revåge 670TM Cool Laser that optimizes results.
Revåge 670TM belongs to a class of lasers that has been clinically and scientifically proven to safely and effectively stimulate cellular metabolism, protein synthesis and regenerate tissue while increasing blood perfusion rates. An increase in blood perfusion rates has been linked to a healthy scalp and hair follicle. Visible results with the Revåge 670TM Cool Laser Therapy occur within weeks.
According to Researcher, Dr. Glen Charles, the Revåge 670TM has shown to increase hair counts in men by an average of 37.78% within 16 weeks of treatment with no incidence of side effects.
According to Researcher, Dr. Glen Charles, the Revåge 670TM has shown to increase hair counts in men by an average of 37.78% within 16 weeks of treatment with no incidence of side effects.
The Picture of Possibilities
Only Revåge 670TM therapy incorporates an integral microscope/camera system that clearly shows each new patient the number of dormant hair follicles in a square centimeter that can be put into the anagen phase of growth. This system dramatically demonstrates improvement throughout therapy.
REFERENCE:
* The REVAGE 670 has not been cleared by the FDA for medical use and any references are purely investigational.
** G M Charles, DO "A Retrospective Study to Investigate and Evaluate the Unanticipated Results of Hair Loss Cessation and Temporary Hair Regrowth in Adult Males Who Had Undergone Low Level Laser Therapy for Hair Wellness" Medical Insight March/April 2006
Only Revåge 670TM therapy incorporates an integral microscope/camera system that clearly shows each new patient the number of dormant hair follicles in a square centimeter that can be put into the anagen phase of growth. This system dramatically demonstrates improvement throughout therapy.
REFERENCE:
* The REVAGE 670 has not been cleared by the FDA for medical use and any references are purely investigational.
** G M Charles, DO "A Retrospective Study to Investigate and Evaluate the Unanticipated Results of Hair Loss Cessation and Temporary Hair Regrowth in Adult Males Who Had Undergone Low Level Laser Therapy for Hair Wellness" Medical Insight March/April 2006
| revage_670.doc |
